There are some new tools to help this respiratory virus season: over-the-counter tests that can identify whether an illness ...

SG Americas Securities LLC purchased a new position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor ...

Yuka Manabe and her team at the Center for Innovative Diagnostics for Infectious Diseases aim to improve global health with ...

Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...

A new study published in Brain, Behavior, and Immunity has found that young adults who have recovered from COVID-19 show ...

Flu season is here with some other ickiness joining the petri dish party, including allergies, strep, pneumonia, COVID-19 and norovirus.

I know there is both a growing interest in – and quite a bit of confusion about – the state of COVID-19 antibody testing. I wanted to take a moment to clear up some of the confusion.

Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...